Martin J. Raftery
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.
Journal: Cancer cell international
Published: December 10, 2024
Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
Journal: BMC cancer
Published: August 25, 2023
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: March 28, 2023
Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
Journal: Frontiers in immunology
Published: February 15, 2023
Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry.
Journal: Cell host & microbe
Published: September 28, 2022
Epstein-Barr virus, interleukin-10 and multiple sclerosis: A ménage à trois.
Journal: Frontiers in immunology
Published: August 26, 2022
HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2.
Journal: Viruses
Published: December 17, 2020
Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology.
Journal: Frontiers in immunology
Published: September 28, 2020
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.
Journal: Nature communications
Published: September 24, 2020
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
Journal: Advances in biological regulation
Published: June 26, 2020
Last Updated: 09/26/2026